Dr. Wang Chang Jie
The main characteristic of this is the anatomy of the uterine membrane to the uterus, which leads to the symptoms of menstruation, pain and infertility. The treatment of this disease usually varies according to the specific circumstances of the patient, including medication, surgical treatment, etc.
However, the experience of two uterine patients in recent days has generated widespread concern and discussion. The uterus sizes of the two patients were 5.9*6.2*4.5 and 6.8* 6.5*6.2 cm, respectively, and the clinical symptoms were not serious and were all minor. However, during their respective visits to the local Sancha Hospital, they were advised to use advanced hormone needles for treatment. The injection is required once a month, at a cost of up to RMB 1,500 each, for a total of six injections. Moreover, after six injections, there is a very high rate of relapse.
This treatment has raised questions for professional clinicians and patients who have been engaged in long-term discussions on the conservative treatment of Western and Central medicines. Is there a need to directly promote the referral of this high hormonal needle to patients in cases where uterine increase is only minor? Or do you suggest that the patient try with other Chinese and western oral drugs and, if there is a real lack of control or improvement, that he or she is recommended to the patient for this type of advanced hormone needle? Also, even in cases of severe uterus growth, after six injections of this type of advanced hormone needle, are consideration given to recommending that patients continue to take small doses of hormonal drugs to sustain their effects?
In principle, treatment for uterine aemia should be based on the principles of simplicity to complexity and weight to weight. In such minor cases, general medications, such as souping, oral contraception, inflammation drugs, etc., should be used to alleviate symptoms and control the development of the disease. If these methods are not effective, more complex and expensive treatments are considered.
The high cost and potential side effects of advanced hormone needles, while effective in mitigating symptoms in some cases, also make their application relatively limited. For patients in general financial conditions, such treatment programmes are undoubtedly a heavy burden. In addition, the long-term use of hormone-type drugs may have adverse effects on the body, such as osteoporosis, weight gain, etc., and therefore the advantages and disadvantages need to be carefully weighed.
From an ethical and medical point of view, doctors should develop treatment programmes that take fully into account the real needs and economic situation of patients, rather than blindly pursuing high-profit treatment. Medical behaviour should be based on the best interests of the patient and not simply on the pursuit of economic benefits.
The treatment experience of this uterus patient is indeed deplorable. It was to be hoped that in future, the medical staff would focus more on humanized services, rationalize treatment programmes and effectively safeguard the rights and health of patients. At the same time, it is hoped that the patient will be able to learn more about his or her treatment and make rational choices about his or her treatment.
Basic knowledge of uterine aemia
The causes of hysteria, which is a chronic disease, are not yet fully known and may be related to, inter alia, uterine membranes damage and immune system anomalies. The main symptoms of the disease include menstruation, increased menstruation, pain, and infertility. Diagnosis is more difficult because of the diversity of the symptoms and their ease of confusion with other gynaecological diseases, which are usually determined by means of visual tests such as ultrasound, MRI etc.
Principles and approaches to treatment
It is regrettable that Dr. Wang Jie, who has been dealing with this disease for more than two decades, has written many of these articles to advise patients, many of whom have not been consulted. So here again, in this article. In general, the following principles are generally followed:
Individualized treatment: individualized treatment programmes are developed on the basis of the specific circumstances of the patient, such as age, severity of symptoms, fertility requirements, etc. Simplicity to complexity: Start with simple treatments, such as drug treatment, and consider more complex treatments if they are ineffective. Integrated treatment: Combining multiple treatments to achieve optimal treatment.
Common treatment methods include:
Drug treatment: When a short-term test of the medium-medicine medicine programme is not a good way to improve the situation, the combination or simple oral contraception, non-paralytic anti-inflammation drugs (NSAIDs), and pregnancy hormones are used to alleviate symptoms and control the development of the disease. Surgical treatment, such as uterine hysterectomy, hysterectomy (also known as u-type surgery) and hysteresis (UAE), applies to patients whose medication is ineffective or seriously ill. Conservative treatment, such as HIFU, freezing and digestion, and the installation of the Manmoon Ring, applies to patients who wish to retain their reproductive function.The debate over advanced hormones.
Advanced hormonal needles do in some cases effectively mitigate the symptoms of uterine aemia, but their high cost and potential side effects also make their application relatively limited. The long-term use of hormone-type drugs can have adverse effects on the body, such as osteoporosis, weight gain, emotional fluctuations, etc. Therefore, the advantages and disadvantages need to be carefully weighed when using them.
Mistreatment
Returning to the experience of the first two patients, their uterus sizes were only 5.9*6.2*4.5 and 6.8*6.5*6.2 cm, respectively, in light condition. In these cases, Dr. Wang Zhangjie is usually treated first with generic drugs, such as the Chinese drug test, the Chinese drug, the Chinese pharmacist tonic, the Chinese pharmacist tonic for a period of 22 days during a period of seven days, and, in the higher cases, the four-day haemorrhagic tonic for a period of four days, which improves clinical symptoms to varying degrees. If the clinical symptoms cannot be significantly improved during a cycle, consideration is given to co-opting or simply oral Western pill, non-synthetic anti-inflammation drugs, etc., to mitigate symptoms and control the development of the disease. If these methods are not effective, more complex and expensive treatments are considered.
However, the decision of the clinicians to directly advise them on the use of advanced hormonal needles is clearly inconsistent with the usual treatment principles. First, this treatment ignores the principle of individualized treatment and does not take into account the specific circumstances and needs of the patient. Second, the high costs and potential side effects of advanced hormone needles have not been adequately assessed and communicated. Finally, this approach may reflect the fact that some health-care institutions ignore the best interests of patients in their pursuit of economic benefits.
Medical ethics and responsibility
Medical behaviour should be based on the best interests of the patient and not simply on the pursuit of economic benefits. Doctors should develop treatment programmes that take fully into account the real needs and financial situation of patients, rather than blindly pursuing high-profit treatment. Medical ethics and ethics are at the heart of health services, and any deviation from this core should be condemned and corrected.
Patient rights and choices
Patients should have the right to know their condition and the advantages and disadvantages of the various treatments in order to make informed choices. To that end, Dr. Wang Jie, who has been working on a 10-year-old programme for the conservative treatment of uteroemia, recommends that patients should be more knowledgeable and rational in choosing their own treatment. At the same time, medical institutions and doctors should fulfil their obligation to inform and ensure that patients make well-informed decisions. Before going to the clinic, there must be a detailed understanding of the general treatment and knowledge of uterine aemia, so that it can be measured in mind, then a clinical doctor who specializes in the treatment of the disease, and then a discussion with his family before making a choice. If it is not possible to find a guide and a recommendation for treatment, then you can click directly on the heading that follows, and read: ” Clinical summary for more than 20 years: guidelines and recommendations for treatment of uterine aemia ” .
Annex: Advanced hormonal needles, mainly the following common drugs:
The high-level hormonal needles that are currently used in the country ‘ s clinical practice are: commercial name: Daphrin (chemical name: injection of acryrin accelerant) and injection of acrein microball with acrylic acid, trade name: Dabiga (chemical name: acetic acid currin injection fluid), Gonarrin (Chinese alias: cedarin estrogen release hormones), trade name: Noreed (chemical name: Goscherin acrein acretation agent). Of these, the two most frequently used — Dafirin and Noreed — are based on hormonal treatment, pain relief and temporary confinement.
Oral hormone drugs, common drugs in the country:
Tenosterin tablets (trade names: scaffolding), danaze capsules, impregnated trichloroketone capsules (trade names: intramersals), cyclopropanone tablets (general contraceptive pills), mifiskets, etc.
The above-mentioned high hormonal needles and oral hormonal drugs, all of which are temporary absconding and control of the condition, but for a period of time, the vast majority of the health stoves and clinical symptoms are gradually returning to their condition.
Concluding remarks
The treatment experience of the two patients with uterine aemia is indeed deplorable. It was to be hoped that in future, the medical staff would focus more on humanized services, rationalize treatment programmes and effectively safeguard the rights and health of patients. At the same time, it is hoped that the patient will be able to learn more about his or her treatment and make rational choices about his or her treatment. The true value and significance of health services can only be realized through the joint efforts of both the medical and the medical communities.
In conclusion, thank the auditors and the network for their hard work and service!
The author ‘ s brief: Dr. Wang Changjie, an ethnic Chinese from Yanning County, Jiangsu Province, has been working in Chinese medicine for more than 30 years and has specialized in the areas of haemorrhagic deficiency, pain and uterine aemia for more than 20 years. Two Chinese drug formulations were patented as Chinese drug inventions and two Chinese drug formulations were listed as one of the first provincial protection projects. During this period, over 200 original web articles were written and nearly 100 medical videos were produced on these aspects. Dr. Wang Jie will continue to write and publish original articles on these issues.
